Skip to main content
SpringerLink
Log in

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis

  • Reply
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Salomon T, Nganoa C, Gac AC, Fruchart C, Damaj G, Aide N, et al. Assessment of alteration in liver (18)F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. Eur J Nucl Med Mol Imaging. 2018;45:941–50. https://doi.org/10.1007/s00259-017-3914-y.

    Article  PubMed  Google Scholar 

  2. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.

    Article  CAS  PubMed  Google Scholar 

  3. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer – a PET study. J Nucl Med. 1993;34:1–6.

    CAS  PubMed  Google Scholar 

  4. Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44:97–110. https://doi.org/10.1007/s00259-017-3690-8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, et al. Report of the 6th International Workshop on PET in lymphoma. Leuk Lymphoma. 2017;58:2298–303. https://doi.org/10.1080/10428194.2017.1298752.

    Article  PubMed  Google Scholar 

  6. Baudino B, D’Agata F, Caroppo P, Castellano G, Cauda S, Manfredi M, et al. The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. Q J Nucl Med Mol Imaging. 2012;56:559–68.

    CAS  PubMed  Google Scholar 

  7. Ponto LL, Menda Y, Magnotta VA, Yamada TH, Denburg NL, Schultz SK. Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study. Int J Geriatr Psychiatry. 2015;30:587–94. https://doi.org/10.1002/gps.4189.

    Article  PubMed  Google Scholar 

  8. Zimmer P, Mierau A, Bloch W, Struder HK, Hulsdunker T, Schenk A, et al. Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leuk Lymphoma. 2015;56:347–52. https://doi.org/10.3109/10428194.2014.915546.

    Article  CAS  PubMed  Google Scholar 

  9. Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35:1104–9.

    CAS  PubMed  Google Scholar 

  10. Beauregard JM, Hofman MS, Kong G, Hicks RJ. The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging. 2012;39:50–6. https://doi.org/10.1007/s00259-011-1937-3.

    Article  CAS  PubMed  Google Scholar 

  11. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller S, et al. Reply to G. Keramida et al. J Clin Oncol. 2015;33:4121–2. https://doi.org/10.1200/jco.2015.63.2125.

    Article  PubMed  Google Scholar 

  12. Meignan M, Cottereau AS. Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again. Leuk Lymphoma. 2018;59:523–5. https://doi.org/10.1080/10428194.2017.1368078.

    Article  PubMed  Google Scholar 

  13. Barrington SF, Sulkin T, Forbes A, Johnson PWM. All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting. Eur J Nucl Med Mol Imaging. 2018;45:316–7. https://doi.org/10.1007/s00259-017-3893-z.

    Article  PubMed  Google Scholar 

  14. Enilorac B, Lasnon C, Nganoa C, Fruchart C, Gac AC, Damaj G, et al. Does PET reconstruction method affect Deauville scoring in lymphoma patients? J Nucl Med. 2018;59:1049–55. https://doi.org/10.2967/jnumed.117.202721.

    Article  PubMed  Google Scholar 

  15. Lasnon C, Enilorac B, Aide N. Reply to: "All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting". Eur J Nucl Med Mol Imaging. 2018;45:878–81. https://doi.org/10.1007/s00259-018-3938-y.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are indebted to Prof. Rodney Hicks, Peter MacCallum Cancer Centre, and University of Melbourne, Australia. for his advice.

Author information

Authors and Affiliations

  1. Nuclear medicine Department, University Hospital, Caen, France

    Nicolas Aide & Thibault Salomon

  2. INSERM ANTICIPE, University of Caen, Caen, France

    Nicolas Aide & Charline Lasnon

  3. François Baclesse cancer Centre, Caen, France

    Charline Lasnon

Authors
  1. Nicolas Aide
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thibault Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charline Lasnon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas Aide.

Ethics declarations

Conflicts of interest

None.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

In accordance with European regulations, French observational studies without any additional therapy or monitoring procedures do not need the approval of an ethics committee. Nonetheless, we sought approval to collect data for our study from the National Committee for Data Privacy, the National Commission on Informatics and Liberty (CNIL), with registration no. 2,080,317 v 0.

Additional information

This reply refers to the article https://doi.org/10.1007/s00259-018-4086-0.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aide, N., Salomon, T. & Lasnon, C. Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis. Eur J Nucl Med Mol Imaging 45, 2233–2234 (2018). https://doi.org/10.1007/s00259-018-4087-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-4087-z

Search

Navigation